Desmanos, Arman C.
HRN: 26-48-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/24/2025
CLINDAMYCIN 300MG (CAP)
01/24/2025
02/06/2025
PO
300mg
Q6
Osteomyelitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes